View in EDS HTML Full Text PDF Full Text

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy.

Saved in:
Bibliographic Details
Title: Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy.
Authors: Seremet, Teofila1,2 (AUTHOR) teofila.caplanusi@uzbrussel.be, Jansen, Yanina1 (AUTHOR) yanina.jansen@uzbrussel.be, Planken, Simon1 (AUTHOR) simon.planken@uzbrussel.be, Njimi, Hassan3 (AUTHOR) hnjimi@ulb.ac.be, Delaunoy, Mélanie4 (AUTHOR) Melanie.Delaunoy@erasme.ulb.ac.be, El Housni, Hakim4 (AUTHOR) Hakim.ElHousni@erasme.ulb.ac.be, Awada, Gil1 (AUTHOR) gil.awada@uzbrussel.be, Schwarze, Julia Katharina1 (AUTHOR) julia.katharina.schwarze@vub.be, Keyaerts, Marleen5 (AUTHOR), Everaert, Hendrik5 (AUTHOR), Lienard, Danielle2 (AUTHOR) danielle.lienard@erasme.ulb.ac.be, Del Marmol, Véronique2 (AUTHOR) Veronique.Del.Marmol@erasme.ulb.ac.be, Heimann, Pierre4 (AUTHOR) Pierre.Heimann@erasme.ulb.ac.be, Neyns, Bart1 (AUTHOR) bart.neyns@uzbrussel.be
Source: Journal of Translational Medicine. 9/5/2019, Vol. 17 Issue 1, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-019-2051-8